Bleeding events occurred substantially less often with the lower dose of aspirin, reported John Burn, MD, of Newcastle ...

Prof Sir John Burn, from Newcastle University, said he would ask health regulators to formally advise a low dose of 75mg be ...

Aspire Biopharma enrolls last patient in phase 1 trial of its oral transmucosal fast-acting high-dose aspirin formulation: Estero, Florida Thursday, June 26, 2025, 18:00 Hrs [IST] ...

Here are the top tips on correctly identifying a heart attack and helping quickly during an emergency, according to ...

Obesity remains one of the greatest health challenges worldwide, leading to diabetes, heart disease, and increased healthcare ...

Ever found yourself staring at a shelf full of supplement bottles, thinking, “Maybe I need all of these?” We’ve all been there. Glowing skin? Pop a pill. Trouble sleeping? There’s a capsule for that.

During a live event, Mojtaba Akhtari, MD, discussed the goals and treatment approach for patients with low-risk polycythemia ...

Investigators evaluated the efficacy and safety of different doses of MK-2060, a monoclonal antibody against Factor XI, to prevent vascular access clotting in patients receiving hemodialysis via an ...

Early results from the phase 1 SANRECO trial suggest that divesiran is safe and well tolerated, and may reduce the need for phlebotomy in patients with polycythemia vera by increasing hepcidin levels ...

Dr. Reiner and others have identified genetic variations that predict CRP levels, and variations that predict heart attack ...